0001728411-18-000001.txt : 20180118
0001728411-18-000001.hdr.sgml : 20180118
20180117191024
ACCESSION NUMBER: 0001728411-18-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180117
EFFECTIVENESS DATE: 20180118
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DMC Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001728411
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-303493
FILM NUMBER: 18532612
BUSINESS ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: (303) 210-2829
MAIL ADDRESS:
STREET 1: 5333 EUCLID AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80303
D
1
primary_doc.xml
X0708
D
LIVE
0001728411
DMC Biotechnologies, Inc.
5333 EUCLID AVENUE
BOULDER
CO
COLORADO
80303
(303) 210-2829
DELAWARE
None
None
Corporation
true
2017
Matthew
L.
Lipscomb
c/o DMC Biotechnologies, Inc.
5333 Euclid Avenue
Boulder
CO
COLORADO
80303
Executive Officer
Director
Michael
D.
Lynch
c/o DMC Biotechnologies, Inc.
5333 Euclid Avenue
Boulder
CO
COLORADO
80303
Director
Rob
van der Meij
c/o DMC Biotechnologies, Inc.
5333 Euclid Avenue
Boulder
CO
COLORADO
80303
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-01-04
false
true
false
0
2499999
1166666
1333333
Offer and Sale of Series Seed Preferred Stock (and the shares issuable thereunder)
false
1
0
0
0
false
DMC Biotechnologies, Inc.
Matthew L. Lipscomb
Matthew L. Lipscomb
Chief Executive Officer
2018-01-11